BioXcel Therapeutics Announces Positive Phase 2 Topline Results from Columbia University-Led Study of BXCL501 for Treatment of Opioid Withdrawal

BXCL501 demonstrated clinical benefits and favorable tolerability profile for treatment of opioid withdrawal symptoms Results from this NIDA-funded study support potential future development of ...
Yahoo Finance

America First Defense Secures License from Navy for Counter-UAS System Designed to Defeat Hostile Drones

Gaxos’ Stake in America First Defense Positions Company at Forefront of Counter-UAS Technology Roseland, NJ, March 05, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company ...

Kroger Reports Fourth Quarter and Full-Year 2025 Results andAnnounces Guidance for 2026

The Kroger Co. (NYSE: KR) today reported its fourth quarter and fiscal year 2025 results, provided 2026 guidance, and shared progress on key priorities.

Palladyne AI Reports Fourth Quarter and Full Year 2025 Results and Reiterates 2026 Revenue Guidance of $24 to $27 Million

Palladyne AI Reports Fourth Quarter and Full Year 2025 Results and Reiterates 2026 Revenue Guidance of $24 to $27 Million ...

Why Lumen Stock Plummeted 19.4% Last Month and Has Kept Falling In March

Lumen (NYSE: LUMN) stock got hit with a substantial valuation pullback in February. The company's share price declined 19.4% in a month that saw the S&P 500 decline 0.9% and the Nasdaq Composite fall ...